Idarucizumab
Indication
For adult patients treated with Pradaxa (dabigatran etexilate) when rapid reversal of its anticoagulant effects is required for emergency surgery/urgent procedures or in life-threatening or uncontrolled bleeding
Red
Brand:
Praxbind®
Nice TA:
Commissioning responsibility:
CCG
PbR excluded:
Yes
BNF chapter:
Cardiovascular system
Background
Idarucizumab (Praxbind®) is recommended for adult patients treated with Pradaxa (dabigatran etexilate) when rapid reversal of its anticoagulant effects is required for emergency surgery/urgent procedures (which cannot be performed safely while anticoagulated or reasonably be delayed) or in life-threatening or uncontrolled bleeding.
Recommendation
LSCMMG Recommendation:
Red
Reason for decision:
Specialist medicine
Supporting documents: